Welcome Guest
Home » Reports

Market for Cancer Biomarkers, 2017-2027


Publication Date : March 2018

One of the pillars of personalised medicine is biomarkers, which are finding increasing use in both research and development, and commercial diagnostics. They have the potential to cut the time and cost of drug development, one of the major challenges facing the biopharmaceutical industry. Also, the commercial use of biomarkers helps save the cost of treatment by avoiding their use in patients who will not benefit from the therapy. Cancer is the leading therapeutic area of interest for biomarker discovery, with several biomarker based diagnostics available in the market. Our report aims to analyse the market for cancer biomarkers, opportunities in the market for drug and diagnostic developers, and the latest industry trends.

Click here to know more

Upcoming Titles [ View all ]

Copyright © Roots Analysis. All Rights Reserved.
website security